Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria

Cell Biochemistry and Function

Volumn 26, Issue 5, 2008, Pages 620-631

  Pupure, Jolanta ^a   Fernandes, Maria A S ^b   Santos, Maria S ^b   Moreno, António J M ^b   Kalvinsh, Ivars ^c   Klusa, Vija ^a   Oliveira, Catarina R ^d  

^a UNIVERSITY OF LATVIA   (Latvia)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

AZT; Mildronate; Mitochondria; Rat liver; Respiratory complex I

Indexed keywords

MILDRONATE; ZIDOVUDINE;

ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; LIVER TOXICITY; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ANIMALS; ANTIMETABOLITES; CELL RESPIRATION; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ENERGY METABOLISM; MALE; METHYLHYDRAZINES; MITOCHONDRIA, LIVER; MITOCHONDRIAL DISEASES; PERMEABILITY; RATS; RATS, WISTAR; ZIDOVUDINE;

MUS; RATTUS;

EID: 48249102367     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1486     Document Type: Article

References (42)

1. Hajnoczky G, Csordas G, Das S, et al. Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 2006; 40: 553-560.
2. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-387.
3. Michael TL, Beal MR Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-795.
4. Longley MJ, Clark S, Yu Wai Man C, et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006; 78: 1026-1034.
5. DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol 2006; 18: 636-641.
6. Mootha VK, Handschin C, Arlow D, et al. Erralpha and Gabpa/ b specify PGC-1 alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 2004; 101: 6570-6575.
7. St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127: 397-408.
8. DiMauro S, Mancuso M. Mitochondrial diseases: therapeutic approaches. Biosci Rep 2007; 27: 125-137.
9. Tsoko M, Beauseigneur F, Gresti J, et al. Enhancment of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and gamma-butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 1995; 49: 1403-1410.
10. Klusa V, Pupure J, Isajevs S, et al. Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug. Basic Clin Pharmacol Toxicol 2006; 99: 323-328.
11. Hayashi Y, Kiromoto T, Asaka N, et al. Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction. Eur J Pharmacol 2000; 395: 217-224.
12. Asaka N, Muranaka Y, Kirimoto T, Miyake H. Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts. Fundam Clin Pharmacol 1998; 12: 158-163.
13. Spaniol M, Brooks H, Auer L, et al. Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 2001; 268: 1876-1887.
14. Dambrova M, Liepinsh E, Kalvinsh I. Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 2002; 9: 155-159.
15. Lynx MD, McKee EE. 3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria. Biochem Pharmacol 2006; 72: 239-243.
16. Petit F, Fromenty B, Owen A, Estaquier J. Mitochondria are sensors for HIV drugs. Trends Pharmacol Sci 2005; 26: 258-264.
17. Corcuera T, Alonso MJ, Picazo A, et al. Hepatic morphological alterations induced by zidovudine (ZDV) in an experimental model. Pathol Res Pract 1996; 192: 182-187.
18. Lewis W. Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions. Antiviral Res 2003; 58: 189-197.
19. Lynx MD, Bentley AT, McKee EE. 3′-Azido-3′-deoxythimidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity. Biochem Pharmacol 2006; 71: 1342-1348.
20. O'Neil MJ. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th edn. Merck and Co., Inc.: White-house Station, NJ, 2001; 1809.
21. Gazotti P, Malmstron K, Crompton MA. Laboratory manual on transport and bioenergetics. In Membrane Biochemistry, Carafoli E, Semenza G (eds). Springer: New York, 1979; 62-69.
22. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J BiolChem 1949; 177: 751-766.
23. Chance B, Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol 1956; 17: 65-134.
24. Kamo N, Muratsugu M, Hongoh R, Kobatake N. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol 1979; 49: 105-121.
25. Costantini P, Chernyak BV, Petronilli V, Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 1996; 271: 6746-6751.
26. 2 generation in isolated mitochondria. J Bioenerg Biomembr 2002; 34: 227-233.
27. Broekemeier KM, Dempsey ME, Pfeiffer DR. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 1989; 264: 7826-7830.
28. Corcuera Pindado MT, Lopez Bravo A, Martinez-Rodriguez R, et al. Histochemical and ultrastructural changes induced by zidovudine in mitochondria of rat cardiac muscle. Eur J Histochem 1994; 38: 311-318.
29. McCurdy DT, Kennedy JM. AZT decreases rat myocardial cytochrome oxidase activity and increases beta-myosin heavy chain content. J Mol Cell Cardiol 1998; 18: 1979-1989.
30. Badley AD, Roumier T, Lum JJ, Kroemer G. Mitochondrion-mediated apoptosis in HIV-1 infection. Trends Pharmacol Sci 2003; 24: 298-305.
31. Akahira M, Hara A, Abiko Y. Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart. Fundam Clin Pharmacol 1997; 11: 356-364.
32. Armstrong JS. The role of the mitochondrial permeability transition in cell death. Mitochondrion 2006; 5: 225-234.
33. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Resp J 2000; 16: 534-554.
34. Pereira LF, Oliveira MBM, Carnieri EGS. Mitochondrial sensitivity to AZT. Cell Biochem Funct 1998; 16: 173-181.
35. Lund KC, Wallace KB. Direct effects of nucleoside reverse transcriptase inhibitors on rat cardiac mitochondrial bioenergetics. Mitochondrion 2004; 4: 193-202.
36. Komarov AM, Hall JM, Weglicki WB. Azidothymidine promotes free radical generation by activated macrophages and hydrogen peroxide-iron-mediated oxidation in a cell-free system. Biochim Biophys Acta 2004; 1688: 257-264.
37. De la Asunción JG, Del Olmo ML, Sastre J, et al. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. J Clin Invest 1998; 102: 4-9.
38. Lamperth L, Dalakas MC, Dagani F, Anderson J, Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest 1991; 65: 742-751.
39. Modica-Napolitano JS. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun 1993; 194: 170-177.
40. Lund KC, Wallace KB. Adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors. Toxicol Appl Pharmacol 2008; 226: 94-106.
41. Chiu DT, Duesberg PH. The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy. Genetica 1995; 95: 103-109.
42. Dzerve V, Matisone D, Kukulis I, et al. Mildronate improves peripheral circulation in patients with chronic heart failure: results of a clinical trial. Sem Cardiol 2005; 11: 1648-7966.